Document Detail


Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
MedLine Citation:
PMID:  16051419     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Patients with chronic liver disease (CLD) have an increased prevalence of osteoporosis. However, there is limited information about the effects of end-stage liver disease on bone metabolism and bone mineral density values in postmenopausal women. The aim of this study was to investigate the effects of chronic liver disease on bone mineral density (BMD) and bone metabolism markers in postmenopausal women. METHODS: We studied BMD by using dual-energy X-ray absorptiometry (DEXA), biochemical markers of bone turnover and calcium-parathyroid hormone (PTH)-Vitamin D axis in 22 postmenopausal women with CLD. Control group consisted of randomly recruited 30 healthy postmenopausal women. RESULTS: Based on WHO criteria, the prevalence of osteoporosis was significantly higher in patients with CLD (72 versus 33%) compared to healthy postmenopausal women. Bone loss was more significant at the lumbar spine than femur in the study group. Urinary excretion of bone resorption marker deoxypyridinoline was increased significantly in patients with CLD. There were no significant differences in bone formation markers (osteocalcin and bone alkaline phosphatase) between the groups. CONCLUSIONS: CLD increases the prevalence of osteoporosis in postmenopausal women, particularly in the lumbar spine. Increased bone resorption seems to be the main reason for osteoporosis in these patients. We suggest that treatment strategies should be improved in these women to protect them from subsequent fractures.
Authors:
Sevinc Uretmen; Mert Gol; Dilek Cimrin; Esra Irmak
Related Documents :
11703889 - Vitamin d status and bone mineral density of veiled and unveiled turkish women.
11405079 - Understanding barriers to preventive health actions for occupational noise-induced hear...
1952779 - Osteocalcin and bone alkaline phosphatase in the serum of women with liver disease.
17354199 - Osteoprotegerin--does it play a protective role in the pathogenesis of bone loss in obe...
10499969 - Low bone mass in premenopausal parous women: identification and the effect of an inform...
8293259 - A comparison of reference bone mineral density measurements derived from two sources: r...
7785479 - Mmpi performance among women with bulimia: a cluster-analytic study.
20069559 - First-trimester markers for the prediction of pre-eclampsia in women with a-priori high...
11535209 - Young women requesting emergency contraception are, despite contraceptive counseling, a...
Publication Detail:
Type:  Journal Article     Date:  2005-07-26
Journal Detail:
Title:  European journal of obstetrics, gynecology, and reproductive biology     Volume:  123     ISSN:  0301-2115     ISO Abbreviation:  Eur. J. Obstet. Gynecol. Reprod. Biol.     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-11-01     Completed Date:  2006-02-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375672     Medline TA:  Eur J Obstet Gynecol Reprod Biol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  67-71     Citation Subset:  IM    
Affiliation:
Izmir Ataturk Research and Training Hospital, Department of Internal Medicine, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alkaline Phosphatase / blood,  metabolism
Amino Acids / metabolism,  urine
Bilirubin / metabolism
Biological Markers / metabolism*
Bone Density / physiology*
Bone Remodeling / physiology
Bone and Bones / metabolism*
Calcium / metabolism
Chronic Disease
Cross-Sectional Studies
Female
Femur / anatomy & histology,  physiology
Humans
Liver Diseases / complications,  metabolism*
Lumbar Vertebrae / anatomy & histology,  physiology
Middle Aged
Osteocalcin / blood,  metabolism
Osteoporosis, Postmenopausal / etiology,  metabolism
Parathyroid Hormone / blood
Phosphorus / metabolism
Postmenopause / physiology*
Chemical
Reg. No./Substance:
0/Amino Acids; 0/Biological Markers; 0/Parathyroid Hormone; 104982-03-8/Osteocalcin; 635-65-4/Bilirubin; 7440-70-2/Calcium; 7723-14-0/Phosphorus; 90032-33-0/deoxypyridinoline; EC 3.1.3.1/Alkaline Phosphatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation: re...
Next Document:  Investigation of human colostrum Helicobacter pylori IgA content in lactating women.